Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 949-960 of 2086 results.
"Increased frequency of CVC access is associated with a higher risk of CLABSI. Interventions to reduce CVC access for blood draws can effectively lower CLABSI rates. Identifying and implementing strategies such as use of phlebotomy teams and standardized sampling protocols may help guide hospital policies and improve patient safety outcomes" Davis et al (2025).
"Given an increase in central-line-associated bloodstream infections (CLABSIs) since the COVID-19 pandemic and low compliance with the CLABSI prevention bundle among intensive care unit (ICU) registered nurses (RNs), it is imperative to identify barriers to implementation in the critical care setting" Nguyen et al (2025).
"This study underscores the high prevalence of CRBSIs and the concerning presence of molecular resistance markers in key pathogens. The predominance of carbapenemase genes such as blaNDM, blaKPC, and OXA variants highlights the urgent need for molecular diagnostics and robust antibiotic stewardship in India" Reddy et al (2025).
"A multimodal intervention significantly reduced CLABSI rates in the PICU, demonstrating the importance of comprehensive strategies in infection prevention. However, sustained compliance is essential to maintain these improvements" Subroongruang et al (2025).
"PN is associated with an increased risk of CLABSI in ward patients but not in ICU patients, suggesting context-dependent risk. Further work is needed to determine effective strategies for reducing rates of CLABSI among patients receiving PN hospital-wide and to validate these findings in broader patient populations" Gorsch et al (2025).
"These findings highlight the distal cephalic vein of the forearm as a practical and preferred initial site for peripherally compatible infusions when guided by structured ultrasound assessment, particularly in patients without renal impairment" Ostroff et al (2025).
"We found no significant association between the administration of irritants through midline catheters and catheter-related complications. However, the drug indications for midline catheters need to be further confirmed by well-conducted randomized clinical trials with large cohorts of patients" Zhang et al (2025).
"ICU nurses demonstrated generally inadequate knowledge of CLABSI prevention strategies, with less than one-third (28.2%) showing a high level of knowledge" Kahindi et al (2025).
"Pathway visualization improves PIVC placement accuracy, success rates, and alignment compared to point localization. The findings highlight its potential to improve cannulation in difficult intravenous access (DIVA) patients" Liddelow et al (2025).
"Our findings suggest the role of platelet activation in CADVT in critically ill children. Once confirmed, these biomarkers may be used to identify critically ill children who would benefit from pharmacologic prophylaxis" Regmi et al (2025).
"We sought to characterize thrombolytic agent use for restoration of CVC patency and assess its association with hospital-acquired venous thromboembolism (HA-VTE)" Sochet et al (2025).
"Ultrasound-guided innominate vein cannulation is safer and more effective than landmark-guided subclavian access in children, with higher success rates and fewer complications" Pablo Damián et al (2025).
